A review of public information. No hands-on testing, laboratory inspection or medical review is claimed.
The useful public details
Strut lists sermorelin injection at $119 per month and oral lozenges at $99. The injection listing identifies a 9 mg vial; the oral listing describes a thirty-day supply. The wellness catalog lists a 500 mg NAD+ injection offering at $149. These quantities describe the advertised package, not a dosing instruction.
Sources: Strut Health — sermorelin pricing, Strut Health — wellness catalog, FDA — Strut Health warning letter, February 20, 2026, FDA — compounding questions and answers
What the consultation still has to settle
The sermorelin page includes consultation, follow-ups and shipping in its presentation. Ask whether the final prescription matches the advertised quantity, how auto-refills operate and how to cancel before the next charge. A milligram in one delivery route should not be assumed to provide the same exposure as a milligram in another.
Sources: Strut Health — sermorelin pricing, Strut Health — wellness catalog, FDA — Strut Health warning letter, February 20, 2026, FDA — compounding questions and answers
Regulatory context
FDA issued Strut a warning letter on February 20, 2026 concerning false or misleading compounded semaglutide and tirzepatide marketing, including representations about who compounded the drugs. That letter addresses GLP-1 marketing, not a finding about the particular sermorelin or NAD+ packages reviewed here. We have not established the current resolution status.
Sources: Strut Health — sermorelin pricing, Strut Health — wellness catalog, FDA — Strut Health warning letter, February 20, 2026, FDA — compounding questions and answers
Our assessment
The route and package information are useful for a receipt-level review. We have not verified clinical outcomes, pharmacy production practices or individual licensure. The compounded products listed here are not FDA-approved, and longevity language should not be read as a demonstrated benefit.
Sources: Strut Health — sermorelin pricing, Strut Health — wellness catalog, FDA — Strut Health warning letter, February 20, 2026, FDA — compounding questions and answers
Every offer in our file.
Sermorelin injection
Compounded prescriptionAdvertised monthly auto-refill. The page describes a 9 mg vial; consultation, follow-ups and shipping are included. Final prescription is determined after clinical review.
Sermorelin oral lozenge
Compounded prescriptionThirty-day supply advertised at $99. Consultation, follow-ups and shipping are included; clinical eligibility and prescription apply.
NAD+ 500 mg injection
Compounded prescriptionWellness catalog lists $149 for 500 mg at 200 mg/mL. The reviewed catalog does not establish the exact replenishment interval for every prescription.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Strut Health — sermorelin pricing ↗
Official public information; price and terms checked October 8, 2026.
- Strut Health — wellness catalog ↗
Official public information; price and terms checked October 8, 2026.
- FDA — Strut Health warning letter, February 20, 2026 ↗
Published letter about compounded GLP-1 marketing; subsequent regulatory status is not established by this review.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
- FDA — ingredients for sterile compounding ↗
NAD+ adverse-event reports and ingredient-quality concerns; not a finding about any listed provider.